PHAMAZON OVERSEAS PVT. LTD.
Tasigna 150

Tasigna 150

Send Inquiry
 Tasigna 150 group of the cancer-fighting medications known as antineoplastics, and specifically to the family of medications called protein tyrosine kinase inhibitors.  Tasigna 150 is used to treat adults who have chronic phase (long-lasting) or accelerated phase (fast-growing) forms of chronic myeloid leukemia (CML) that is Philadelphia chromosome positive. It is used when other therapies have been tried, including , and not produced a response, or other therapies have produced unacceptable levels of side effects. The usual recommended adult dose of nilotinib for the treatment of CML that has been previously treated, is 400 mg taken by mouth twice daily.